Andrea Repaci
Overview
Explore the profile of Andrea Repaci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
609
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bisceglia N, Malagrino M, Piazza A, Vandi G, Repaci A, Pagotto U, et al.
Front Endocrinol (Lausanne)
. 2025 Feb;
15:1428640.
PMID: 39963179
Introduction: Normocalcemic primary hyperparathyroidism (NHPT) is considered to be an early stage in the evolution of primary hyperparathyroidism (PHPT). To formulate a correct diagnosis, secondary hyperparathyroidism due to low calcium...
2.
de Biase D, Repaci A, Nigro M, Maloberti T, Carosi F, Pantaleo M, et al.
J Clin Transl Endocrinol
. 2025 Jan;
38:100373.
PMID: 39764277
Thanks to the identification of crucial molecular pathways, the therapeutic landscape for advanced differentiated thyroid tumors (DTCs) has significantly improved during the last ten years. The therapeutic scenario has been...
3.
Marini F, Marcucci G, Giusti F, Arvat E, Benvenga S, Bondanelli M, et al.
Eur J Endocrinol
. 2024 Oct;
191(4):416-425.
PMID: 39365596
Objective: Atypical parathyroid tumor (aPT) and parathyroid carcinoma (PC) are extremely rare parathyroid neoplasms, accounting together for <2% of all parathyroid tumors. They often present an overlapping clinical phenotype, sharing...
4.
Roda M, Valsecchi N, di Geronimo N, Repaci A, Vicennati V, Pagotto U, et al.
Head Face Med
. 2024 Apr;
20(1):22.
PMID: 38561852
Backgrounds: To report the long-term surgical outcomes and the impact on daily life activities of strabismus surgery in patients with Thyroid Associated Orbitopathy (TAO) with and without previous orbital decompression....
5.
Basso C, Colapinto A, Vicennati V, Gambineri A, Pelusi C, Di Dalmazi G, et al.
Endocrine
. 2024 Mar;
85(2):493-508.
PMID: 38498129
Purpose: whole body scan (WBS) performed following diagnostic or therapeutic administration of I-131 is useful in patients with differentiated thyroid carcinoma. However, it can be falsely positive in various circumstances....
6.
De Leo A, Ruscelli M, Maloberti T, Coluccelli S, Repaci A, de Biase D, et al.
Virchows Arch
. 2024 Jan;
484(2):321.
PMID: 38277053
No abstract available.
7.
Aksoy Y, Xu B, Viswanathan K, Ahadi M, Al Ghuzlan A, Alzumaili B, et al.
Histopathology
. 2024 Jan;
84(6):947-959.
PMID: 38253940
Aims: Recently, there have been attempts to improve prognostication and therefore better guide treatment for patients with medullary thyroid carcinoma (MTC). In 2022, the International MTC Grading System (IMTCGS) was...
8.
De Leo A, Ruscelli M, Maloberti T, Coluccelli S, Repaci A, de Biase D, et al.
Virchows Arch
. 2023 Dec;
484(2):289-319.
PMID: 38108848
Tumors of the endocrine glands are common. Knowledge of their molecular pathology has greatly advanced in the recent past. This review covers the main molecular alterations of tumors of the...
9.
Xu B, Viswanathan K, Ahadi M, Ahmadi S, Alzumaili B, Bani M, et al.
Thyroid
. 2023 Oct;
34(2):167-176.
PMID: 37842841
The prognostic importance of and mutations and their relationship to clinicopathologic parameters and outcomes in medullary thyroid carcinoma (MTC) need to be clarified. A multicenter retrospective cohort study was performed...
10.
De Leo A, Serban D, Maloberti T, Sanza V, Coluccelli S, Altimari A, et al.
Int J Mol Sci
. 2023 Feb;
24(4).
PMID: 36835466
The BRAF p.V600E mutation represents the most specific marker for papillary thyroid carcinoma and is potentially related to aggressive behavior and persistent disease. alterations other than the p.V600E are less...